SEARCH

SEARCH BY CITATION

References

  • 1
    Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114: 3943.
  • 2
    Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case–control study. Aliment Pharmacol Ther 2000; 14: 14553.
  • 3
    Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 57785.
  • 4
    Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004; 53: 14718.
  • 5
    Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 292933.
    Direct Link:
  • 6
    Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 317.
  • 7
    Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24: 18299.
  • 8
    Van Hees PA, Van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982; 4: 3336.
  • 9
    Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 1918.
  • 10
    Bernal I, Domènech E, Garcia-Planella E, et al. Medication-taking behaviour in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006; 51: 21659.
  • 11
    Robinson A. Patient-reported compliance with 5-ASA drugs in inflammatory bowel disease: a multi-national study. Gastroenterology 2002; 122: A-499.
  • 12
    Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 13839.
  • 13
    Huser MA, Evans TS, Berger V. Medication adherence trends with statins. Adv Ther 2005; 22: 16371.
  • 14
    Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am J Gastroenterol 1999; 94: 173342.
    Direct Link:
  • 15
    Kane SV, Aikens J, Hanauer SB, et al. Medication regimens are associated with non-adherence in quiescent ulcerative colitis. Am J Gastroenterol 2002; 98: S253.
  • 16
    Robinson A, Bokemeyer B, Cripps S, et al. Towards better patient compliance in IBD: report of an international compliance consensus meeting. Gastroenterol Hepatol 2005; 1: 20615.
  • 17
    Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6: 5929.
  • 18
    Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003; 1: 1703.
  • 19
    Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006; 2: 116.
  • 20
    Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 107490.
  • 21
    Schneider J, Kaplan SH, Greenfield S, et al. Better physician–patient relationships are associated with higher reported adherence to antiviral therapy in patients with HIV infection. J Gen Intern Med 2004; 19: 1096103.
  • 22
    Beach MC, Keruly J, Moore RD. Is the quality of the patient–provider relationship associated with better adherence and health outcomes for patients with HIV. J Gen Intern Med 2006; 21: 6615.
  • 23
    Wroth TH, Pathman DE. Primary medication adherence in a rural population: the role of the patient–physician relationship and satisfaction with care. J Am Board Fam Med 2006; 19: 47886.
  • 24
    Sewitch MA, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003; 98: 153544.
    Direct Link:
  • 25
    Bass MJ, Buck C, Turner L, et al. The physician’s actions and the outcome of illness in family practice. J Fam Pract 1986; 23: 437.
  • 26
    Rost K, Carter W, Inui T. Introduction of information during the initial medical visit: consequences for patient follow-through with physician recommendations for medication. Soc Sci Med 1989; 28: 31521.
  • 27
    Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making. Soc Sci Med 1992; 34: 50713.